Contact
QR code for the current URL

Story Box-ID: 924097

Molecular Health GmbH Kurfuersten-Anlage 21 69115 Heidelberg, Germany https://www.molecularhealth.com/de/
Contact Ms Carla Mertens +49 6221 438512275
Company logo of Molecular Health GmbH
Molecular Health GmbH

Molecular Health To Attend Key Events and Scientific Conferences In The Fourth Quarter 2018

(PresseBox) (Heidelberg / Boston, USA, )
Molecular Health (MH), a leading biomedical company that is transforming molecular data into clinically actionable information for efficient and safer cancer treatment options based on its proprietary Dataome® technology platform, announced that the company is going to attend several industry and scientific conferences in the fourth quarter 2018.

Bill and Melinda Gates Foundation Grand Challenges Meeting. October 15-18, 2018 - Berlin, Germany. Attendance: 1 poster and 1 workshop.

ESMO2018 - European Society for medical oncology congress. October 19-23, 2018 - Munich, Germany. Attendance: Molecular Health booth.

Executive Decision-Making Conference - Portfolio Management. October 23-24, 2018 - Hyatt at the Bellevue, Philadelphia. Attendance: 1 oral presentation.
  • Predicting clinical trial success with Artificial Intelligence, 23 October at 9:30 am AMP 2018 - AMP Conference. October 31 - November 3, 2018 - San Antonio, TX, USA. Attendance: MH Booth 803 and Corporate Workshop.
Personalized Medicine Coalition. November 13-15, 2018 - Harvard, USA. Attendance: Molecular Health Table Presentation.

15. AIO-Herbstkongress 2018 - Update on Medical Oncology. November 15-17, 2018 - Berlin, Germany. Attendance: Molecular Health booth.

Biodata World Congress. November 28-29, 2018 - Basel Congress Center, Basel. Attendance: 1 oral presentation and 1 booth
  • Predicting clinical trial success with Artificial Intelligence, November 29, 2018.

Website Promotion

Website Promotion

Molecular Health GmbH

Molecular Health (MH) is a global computational biomedicine company focused on the capture, curation, integration, and analysis of large data sets in the field of biomedicine and medical products and combining them with novel artificial intelligence and machine learning (AI/ML) technologies to enable precision medicine. Over more than a decade, the company has developed Dataome®, a unique, high-quality curated system that combines clinico-molecular data, drug data and analytical processes. Dataome®, in combination with novel AI/ML technologies, allows for new approaches for prognostic and predictive in silico science that can guide some of the most promising yet most challenging promises of precision medicine. Based on its unique technology MH offers products and solutions for physicians, providers, pharma and laboratories. The company is headquartered in Heidelberg, Germany, the center of cancer research in Europe. The U.S. headquarter is located in Boston, MA.

For more information, visit www.molecularhealth.com

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.
Important note:

Systematic data storage as well as the use of even parts of this database are only permitted with the written consent of unn | UNITED NEWS NETWORK GmbH.

unn | UNITED NEWS NETWORK GmbH 2002–2024, All rights reserved

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.